Skip to main content
Top
Published in: Infectious Agents and Cancer 1/2012

Open Access 01-12-2012 | Research article

HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies

Authors: Paolo Giorgi Rossi, Mario Sideri, Francesca Maria Carozzi, Amina Vocaturo, Franco Maria Buonaguro, Maria Lina Tornesello, Elena Burroni, Luciano Mariani, Sara Boveri, Leandra Maria Zaffina, Francesco Chini, the HPV Prevalence Italian Working Group

Published in: Infectious Agents and Cancer | Issue 1/2012

Login to get access

Abstract

Objective

The aim of this study is to describe the prevalence of HPV types in invasive cervical cancers in Italy from 1996 to 2008.

Methods

A pooled analysis of the three largest case series typed to date was performed. HPV typing was performed on paraffin-embedded slices. Molecular analyses were performed in four laboratories. Multivariate analyses were performed to test the associations between calendar time, age, and geographical area and the proportion of types 16/18.

Results

Out of 574 cancers, 24 (4.2%) were HPV negative. HPV 16 and 18 were responsible for 74.4% (378/508) and 80.3% (49/61) of the squamous cancers and adenocarcinomas, respectively. Other frequent types were 31 (9.5%), 45 (6.4%), and 58 (3.3%) for squamous cancers and 45 (13.3%), 31, 35, and 58 (5.0%) for adenocarcinomas. The proportion of HPV 16 and/or 18 decreased with age (p-value for trend <0.03), while it increased in cancers diagnosed in more recent years (p-value for trend < 0.005).

Conclusions

The impact of HPV 16/18 vaccine on cervical cancer will be greater for early onset cancers. In vaccinated women, screening could be started at an older age without reducing protection.
Literature
1.
go back to reference Ferlay J, Bray F, Pisani P, Parkin DM: Globocan 2002 cancer incidence, mortality and prevalence worldwide IARC Cancer Base N° 5 version 0.2. 2004, Lyon: IARC Press Ferlay J, Bray F, Pisani P, Parkin DM: Globocan 2002 cancer incidence, mortality and prevalence worldwide IARC Cancer Base N° 5 version 0.2. 2004, Lyon: IARC Press
2.
go back to reference Ferlay J, Shin HR, Bray F, Forman D, Mathers C: Parkin DM Globocan 2008 cancer incidence and mortality worldwide IARC Cancer Base N°10 Lyon. 2010, Cancer: France International Agency for Research on Ferlay J, Shin HR, Bray F, Forman D, Mathers C: Parkin DM Globocan 2008 cancer incidence and mortality worldwide IARC Cancer Base N°10 Lyon. 2010, Cancer: France International Agency for Research on
3.
go back to reference Ricciardi A, Largeron N, Giorgi Rossi P, Raffaele M, Cohet C, Federici A, et al: Incidence of invasive cervical cancer and direct costs associated with its management in Italy. Tumori. 2009, 95: 146-152.PubMed Ricciardi A, Largeron N, Giorgi Rossi P, Raffaele M, Cohet C, Federici A, et al: Incidence of invasive cervical cancer and direct costs associated with its management in Italy. Tumori. 2009, 95: 146-152.PubMed
4.
go back to reference Walboomers JM, Jacobs MV, Manos MM, Bossch FX, Kummer JA, Shah KV, et al: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999, 189: 12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.PubMedCrossRef Walboomers JM, Jacobs MV, Manos MM, Bossch FX, Kummer JA, Shah KV, et al: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999, 189: 12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.PubMedCrossRef
5.
go back to reference Bouvard VA, Baan RA, Straif KA, Grosse Y, Secretan B, El Ghissassi F, behalf of the WHO, et al: International Agency for Research on Cancer Monograph Working Group. Lancet Oncol. 2009, 10: 321-322. 10.1016/S1470-2045(09)70096-8.PubMedCrossRef Bouvard VA, Baan RA, Straif KA, Grosse Y, Secretan B, El Ghissassi F, behalf of the WHO, et al: International Agency for Research on Cancer Monograph Working Group. Lancet Oncol. 2009, 10: 321-322. 10.1016/S1470-2045(09)70096-8.PubMedCrossRef
6.
go back to reference de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX: Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007, 7: 453-459. 10.1016/S1473-3099(07)70158-5.PubMedCrossRef de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX: Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007, 7: 453-459. 10.1016/S1473-3099(07)70158-5.PubMedCrossRef
7.
go back to reference de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, et al: Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010, 11: 1048-1056. 10.1016/S1470-2045(10)70230-8.PubMedCrossRef de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, et al: Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010, 11: 1048-1056. 10.1016/S1470-2045(10)70230-8.PubMedCrossRef
8.
go back to reference Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM: Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer. 2011, 128: 927-935. 10.1002/ijc.25396.PubMedCrossRef Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM: Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer. 2011, 128: 927-935. 10.1002/ijc.25396.PubMedCrossRef
9.
go back to reference Carozzi FM, Tornesello ML, Burroni E, Loquercio G, Carillo G, Angeloni C, for the HPV Prevalence Italian Working Group, et al: Prevalence of Human Papillomavirus Types in High-Grade Cervical Intraepithelial Neoplasia and Cancer in Italy. Cancer Epidemiol Biomarkers Prev. 2010, 19: 2389-2400. 10.1158/1055-9965.EPI-10-0131.PubMedCrossRef Carozzi FM, Tornesello ML, Burroni E, Loquercio G, Carillo G, Angeloni C, for the HPV Prevalence Italian Working Group, et al: Prevalence of Human Papillomavirus Types in High-Grade Cervical Intraepithelial Neoplasia and Cancer in Italy. Cancer Epidemiol Biomarkers Prev. 2010, 19: 2389-2400. 10.1158/1055-9965.EPI-10-0131.PubMedCrossRef
10.
go back to reference Kjaer SK, Frederiksen K, Munk C, Iftner T: Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst. 2010, 102: 1478-1488. 10.1093/jnci/djq356.PubMedPubMedCentralCrossRef Kjaer SK, Frederiksen K, Munk C, Iftner T: Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst. 2010, 102: 1478-1488. 10.1093/jnci/djq356.PubMedPubMedCentralCrossRef
11.
go back to reference Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, et al: Joint European Cohort Study. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ. 2008, 337: a1754-10.1136/bmj.a1754.PubMedPubMedCentralCrossRef Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, et al: Joint European Cohort Study. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ. 2008, 337: a1754-10.1136/bmj.a1754.PubMedPubMedCentralCrossRef
12.
go back to reference Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, et al: The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005, 97: 1072-1079. 10.1093/jnci/dji187.PubMedCrossRef Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, et al: The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005, 97: 1072-1079. 10.1093/jnci/dji187.PubMedCrossRef
13.
go back to reference Quinn M, Babb P, Jones J, Allen E: Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ. 1999, 318 (7188): 904-908. 10.1136/bmj.318.7188.904.PubMedPubMedCentralCrossRef Quinn M, Babb P, Jones J, Allen E: Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ. 1999, 318 (7188): 904-908. 10.1136/bmj.318.7188.904.PubMedPubMedCentralCrossRef
14.
go back to reference van der Aa MA, Pukkala E, Coebergh JW, Anttila A, Siesling S: Mass screening programmes and trends in cervical cancer in Finland and the Netherlands. Int J Cancer. 2008, 122 (8): 1854-1858.PubMedCrossRef van der Aa MA, Pukkala E, Coebergh JW, Anttila A, Siesling S: Mass screening programmes and trends in cervical cancer in Finland and the Netherlands. Int J Cancer. 2008, 122 (8): 1854-1858.PubMedCrossRef
15.
go back to reference Sato S, Makino H, Yajima A, Komatsu S, Fukao A: Cervical cancer screening in Japan. A case–control study. Acta Cytol. 1997, 41: 1103-1106. 10.1159/000332795.PubMedCrossRef Sato S, Makino H, Yajima A, Komatsu S, Fukao A: Cervical cancer screening in Japan. A case–control study. Acta Cytol. 1997, 41: 1103-1106. 10.1159/000332795.PubMedCrossRef
16.
go back to reference Mitchell H, Medley G, Gordon I, Giles G: Cervical cytology reported as negative and risk of adenocarcinoma of cervix: no strong evidence of benefit. Br J Cancer. 1995, 71: 894-897. 10.1038/bjc.1995.172.PubMedPubMedCentralCrossRef Mitchell H, Medley G, Gordon I, Giles G: Cervical cytology reported as negative and risk of adenocarcinoma of cervix: no strong evidence of benefit. Br J Cancer. 1995, 71: 894-897. 10.1038/bjc.1995.172.PubMedPubMedCentralCrossRef
17.
go back to reference Zappa M, Visioli CB, Ciatto S, Iossa A, Paci E, Sasieni P: Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case–control study in Florence. Br J Cancer. 2004, 90: 1784-1786.PubMedPubMedCentral Zappa M, Visioli CB, Ciatto S, Iossa A, Paci E, Sasieni P: Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case–control study in Florence. Br J Cancer. 2004, 90: 1784-1786.PubMedPubMedCentral
18.
go back to reference Sasieni P, Castanon A, Cuzick J: Effectiveness of cervical screening with age: population based case–control study of prospectively recorded data. BMJ. 2009, 339: b2968-10.1136/bmj.b2968.PubMedPubMedCentralCrossRef Sasieni P, Castanon A, Cuzick J: Effectiveness of cervical screening with age: population based case–control study of prospectively recorded data. BMJ. 2009, 339: b2968-10.1136/bmj.b2968.PubMedPubMedCentralCrossRef
19.
go back to reference Mariani L, Monfulleda N, Alemany L, Vizza E, Marandino F, Vocaturo A, et al: Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy. BMC Cancer. 2010, 10: 259-10.1186/1471-2407-10-259.PubMedPubMedCentralCrossRef Mariani L, Monfulleda N, Alemany L, Vizza E, Marandino F, Vocaturo A, et al: Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy. BMC Cancer. 2010, 10: 259-10.1186/1471-2407-10-259.PubMedPubMedCentralCrossRef
20.
go back to reference Sideri M, Cristoforoni P, Casadio C, Boveri S, Igidbashian S, Schmitt M, et al: Distribution of human papillomavirus genotypes in invasive cervical cancer in Italy: a representative, single institution case series. Vaccine. 2009, 27 (Suppl 1): A30-A33.PubMedCrossRef Sideri M, Cristoforoni P, Casadio C, Boveri S, Igidbashian S, Schmitt M, et al: Distribution of human papillomavirus genotypes in invasive cervical cancer in Italy: a representative, single institution case series. Vaccine. 2009, 27 (Suppl 1): A30-A33.PubMedCrossRef
21.
go back to reference Gheit T, Landi S, Gemignani F, Snijders PJ, Vaccarella S, Franceschi S, et al: Development of a sensitive and specific assay combining multiplex PCR and DNAmicroarray primer extension to detect high-risk mucosal human papillomavirus types. J Clin Microbiol. 2006, 44: 2025-2031. 10.1128/JCM.02305-05.PubMedPubMedCentralCrossRef Gheit T, Landi S, Gemignani F, Snijders PJ, Vaccarella S, Franceschi S, et al: Development of a sensitive and specific assay combining multiplex PCR and DNAmicroarray primer extension to detect high-risk mucosal human papillomavirus types. J Clin Microbiol. 2006, 44: 2025-2031. 10.1128/JCM.02305-05.PubMedPubMedCentralCrossRef
22.
go back to reference Cazzaniga M, Gheit T, Casadio C, Khan N, Macis D, Valenti F: Analysis of the presence of the cutaneous and mucosal papillomavirus types in ductal lavage fluid, milk and colostrum to evaluate its role in breast carcinogenesis. Breast Cancer Res Treat. in press Cazzaniga M, Gheit T, Casadio C, Khan N, Macis D, Valenti F: Analysis of the presence of the cutaneous and mucosal papillomavirus types in ductal lavage fluid, milk and colostrum to evaluate its role in breast carcinogenesis. Breast Cancer Res Treat. in press
23.
go back to reference Sandri MT, Riggio D, Salvatici M, Passerini R, Zorzino L, Boveri S, et al: Typing of human papillomavirus in women with cervical lesions: prevalence and distribution of different genotypes. J Med Virol. 2009, 81: 271-277. 10.1002/jmv.21382.PubMedCrossRef Sandri MT, Riggio D, Salvatici M, Passerini R, Zorzino L, Boveri S, et al: Typing of human papillomavirus in women with cervical lesions: prevalence and distribution of different genotypes. J Med Virol. 2009, 81: 271-277. 10.1002/jmv.21382.PubMedCrossRef
24.
go back to reference Guan P, Howell-Jones R, Li N, Bruni L, de Sanjosé S, Franceschi S, et al: Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer. Int J Cancer. 2012, 10.1002/ijc.27485. Guan P, Howell-Jones R, Li N, Bruni L, de Sanjosé S, Franceschi S, et al: Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer. Int J Cancer. 2012, 10.1002/ijc.27485.
25.
go back to reference Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al: Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007, 121: 621-632. 10.1002/ijc.22527.PubMedCrossRef Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al: Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007, 121: 621-632. 10.1002/ijc.22527.PubMedCrossRef
26.
go back to reference Clifford G, Franceschi S: Members of the human papillomavirus type 18 family(alfa-7 species) share a common association with adenocarcinoma of the cervix. Int J Cancer. 2008, 122: 1684-1685.PubMedCrossRef Clifford G, Franceschi S: Members of the human papillomavirus type 18 family(alfa-7 species) share a common association with adenocarcinoma of the cervix. Int J Cancer. 2008, 122: 1684-1685.PubMedCrossRef
27.
go back to reference Visioli CB, Zappa M, Ciatto S, Iossa A, Crocetti E: Increasing trends of cervical adenocarcinoma incidence in Central Italy despite Extensive Screening Programme, 1985–2000. Cancer Detect Prev. 2004, 28 (6): 461-464. 10.1016/j.cdp.2004.07.007.PubMedCrossRef Visioli CB, Zappa M, Ciatto S, Iossa A, Crocetti E: Increasing trends of cervical adenocarcinoma incidence in Central Italy despite Extensive Screening Programme, 1985–2000. Cancer Detect Prev. 2004, 28 (6): 461-464. 10.1016/j.cdp.2004.07.007.PubMedCrossRef
28.
go back to reference Giorgi Rossi P, Chini F, Borgia P, Gasticchi G, Carozzi FM, Confortini M, et al: Epidemiologia del Papilloma virus umano (HPV), incidenza del cancro della cervice uterina e diffusione dello screening: differenze fra macroaree in Italia. Epidemiol & Prev. 2012, 36: 108-119. Giorgi Rossi P, Chini F, Borgia P, Gasticchi G, Carozzi FM, Confortini M, et al: Epidemiologia del Papilloma virus umano (HPV), incidenza del cancro della cervice uterina e diffusione dello screening: differenze fra macroaree in Italia. Epidemiol & Prev. 2012, 36: 108-119.
29.
go back to reference Hildesheim A, Hadjimichael O, Schwartz PE, Wheeler CM, Barnes W, Lowell DM, et al: Risk factors for rapid onset cervical cancer. Am J Obstet Gynecol. 1999, 180: 571-577. 10.1016/S0002-9378(99)70256-5.PubMedCrossRef Hildesheim A, Hadjimichael O, Schwartz PE, Wheeler CM, Barnes W, Lowell DM, et al: Risk factors for rapid onset cervical cancer. Am J Obstet Gynecol. 1999, 180: 571-577. 10.1016/S0002-9378(99)70256-5.PubMedCrossRef
30.
go back to reference Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE: Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst. 2009, 101: 475-487. 10.1093/jnci/djn510.PubMedPubMedCentralCrossRef Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE: Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst. 2009, 101: 475-487. 10.1093/jnci/djn510.PubMedPubMedCentralCrossRef
31.
go back to reference Dal Bello B, Spinillo A, Alberizzi P, Cesari S, Gardella B, Silini EM: Time trends of human papillomavirus type distribution in Italian women with cervical intraepithelial neoplasia (CIN). Gynecol Oncol. 2009, 115: 262-266. 10.1016/j.ygyno.2009.07.029.PubMedCrossRef Dal Bello B, Spinillo A, Alberizzi P, Cesari S, Gardella B, Silini EM: Time trends of human papillomavirus type distribution in Italian women with cervical intraepithelial neoplasia (CIN). Gynecol Oncol. 2009, 115: 262-266. 10.1016/j.ygyno.2009.07.029.PubMedCrossRef
32.
go back to reference Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A, et al: A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res. 2010, 70: 3159-3169. 10.1158/0008-5472.CAN-09-4179.PubMedPubMedCentralCrossRef Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A, et al: A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res. 2010, 70: 3159-3169. 10.1158/0008-5472.CAN-09-4179.PubMedPubMedCentralCrossRef
33.
go back to reference Tornesello ML, Duraturo ML, Salatiello I, Buonaguro L, Losito S, Botti G, Stellato G, et al: Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol. 2004, 74: 117-126. 10.1002/jmv.20154.PubMedCrossRef Tornesello ML, Duraturo ML, Salatiello I, Buonaguro L, Losito S, Botti G, Stellato G, et al: Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol. 2004, 74: 117-126. 10.1002/jmv.20154.PubMedCrossRef
34.
go back to reference Ronco G, Giorgi-Rossi P, Carozzi F, Dalla Palma P, Del Mistro A, De Marco A, et al: Human papillomavirus testing and liquid-based cytology in primary screening among younger women: results at recruitment from the NTCC randomised controlled trial. Lancet Oncol. 2006, 7 (7): 547-555. 10.1016/S1470-2045(06)70731-8.PubMedCrossRef Ronco G, Giorgi-Rossi P, Carozzi F, Dalla Palma P, Del Mistro A, De Marco A, et al: Human papillomavirus testing and liquid-based cytology in primary screening among younger women: results at recruitment from the NTCC randomised controlled trial. Lancet Oncol. 2006, 7 (7): 547-555. 10.1016/S1470-2045(06)70731-8.PubMedCrossRef
35.
go back to reference Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al: American cancer society, american society for colposcopy and cervical pathology, and american society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol. 2012, 137: 516-542. 10.1309/AJCPTGD94EVRSJCG.PubMedCrossRef Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al: American cancer society, american society for colposcopy and cervical pathology, and american society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol. 2012, 137: 516-542. 10.1309/AJCPTGD94EVRSJCG.PubMedCrossRef
36.
go back to reference Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N: European Commission. European Guidelines for Quality Assurance in Cervical Cancer Screening. 2008, Luxembourg: Office for Official Publications of the European Communities, 1-291. 2 Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N: European Commission. European Guidelines for Quality Assurance in Cervical Cancer Screening. 2008, Luxembourg: Office for Official Publications of the European Communities, 1-291. 2
37.
go back to reference Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, Dillner J, et al: Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst. 2008, 100: 622-629. 10.1093/jnci/djn099.PubMedCrossRef Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, Dillner J, et al: Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst. 2008, 100: 622-629. 10.1093/jnci/djn099.PubMedCrossRef
Metadata
Title
HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies
Authors
Paolo Giorgi Rossi
Mario Sideri
Francesca Maria Carozzi
Amina Vocaturo
Franco Maria Buonaguro
Maria Lina Tornesello
Elena Burroni
Luciano Mariani
Sara Boveri
Leandra Maria Zaffina
Francesco Chini
the HPV Prevalence Italian Working Group
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Infectious Agents and Cancer / Issue 1/2012
Electronic ISSN: 1750-9378
DOI
https://doi.org/10.1186/1750-9378-7-26

Other articles of this Issue 1/2012

Infectious Agents and Cancer 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine